Disclosure 11 Page

CHN

KOR

Disclosure 목록
No	Title	Date	Date
216	주요사항보고서(전환사채권발행결정)	엘앤씨바이오	2022.06.28
215	투자판단관련주요경영사항 (무릎 연골 관절염 치료재 MegaCarti®(메가카티®) 품목허가(NDA) 신청)	엘앤씨바이오	2022.06.14
214	기업설명회(IR)개최	엘앤씨바이오	2022.05.31
213	타법인주식및출자증권취득결정	엘앤씨바이오	2022.05.23
212	기업설명회(IR)개최	엘앤씨바이오	2022.05.20
211	투자판단관련주요경영사항 (무릎 연골 관절염 치료재 MegaCarti®(메가카티®) 임상시험(Topline d…	엘앤씨바이오	2022.05.19
210	분기보고서 (2022.03)	엘앤씨바이오	2022.05.13
209	주식등의대량보유상황보고서(일반)	이환철	2022.05.06
208	주식등의대량보유상황보고서(일반)	이환철	2022.04.15
207	유형자산취득결정(종속회사의주요경영사항)	엘앤씨바이오	2022.03.31
206	주식등의대량보유상황보고서(일반)	이환철	2022.03.31
205	사외이사의선임ㆍ해임또는중도퇴임에관한신고	엘앤씨바이오	2022.03.29
204	정기주주총회결과	엘앤씨바이오	2022.03.29
203	사업보고서 (2021.12)	엘앤씨바이오	2022.03.21
202	감사보고서제출	엘앤씨바이오	2022.03.21

검색

L&C Bio Co., Ltd. Business Registration No. (129-86-64008) Privacy Policy Seoul Office / R&D Center 82, Naruteo-ro, Seocho-gu, Seoul (Jamwon-dong) Seoul Office / Sales & Marketing Center Room 201, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul Headquarters / Human Tissue Plant Units 605–607, 474, Dunchon-daero, Suntech City (Sangdaewon-dong), Jungwon-gu, Seongnam-si, Gyeonggi-do Pharmaceutical Plant Building A, 1F, 104, Gongdan 2-ro, (Sinsohyeon-dong), Anseong-si, Gyeonggi-do L&C ES Headquarters 2F #203–204, 90, Centum-dong-ro, L&C ES (Jaesong-dong, Centum Phil Bldg. 2), Haeundae-gu, Busan L&C ES R&D Center 4F, 76, Naruteo-ro (ImageUp Bldg.), Seocho-gu, Seoul L&C Medicare Headquarters Room 202, 105, HyoRyeong-ro (Beomchang Bldg., Bangbae-dong), Seocho-gu, Seoul L&C China Headquarters No. 97, Building 32-1, Jixiangnan Yuan, Luojia Town, Kunshan, Jiangsu, China

Cutomer Service

+82-2-541-8577